These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27793000)

  • 21. [Surgical treatment of advanced laryngeal cancer with preservation of laryngeal function].
    Jin T; Pan XL; Lei DP; Liu DY; Xia M; Wei DM; Qian Y; Sun RJ; Xie G; Luan XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):924-9. PubMed ID: 24444638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
    Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
    Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.
    Lehnerdt GF; Franz P; Winterhoff S; Bankfalvi A; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
    Laryngoscope; 2008 Dec; 118(12):2172-6. PubMed ID: 19029852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Analysis of Preoperative Inflammatory Biomarkers in Patients With Laryngeal Squamous Cell Carcinoma.
    Xun Y; Wang M; Sun H; Shi S; Guan B; Yu C
    Ear Nose Throat J; 2020 Jul; 99(6):371-378. PubMed ID: 31569972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
    Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
    Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma.
    Ma J; Liu S; Zhang W; Zhang F; Wang S; Wu L; Yan R; Wu L; Wang C; Zha Z; Sun J
    Pathology; 2016 Dec; 48(7):691-696. PubMed ID: 27780595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma.
    Zhang H; Sun M; Zhou D; Gorur A; Sun Z; Zeng W; Cata JP; Chen W; Miao C
    Br J Anaesth; 2020 Nov; 125(5):722-729. PubMed ID: 32900505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
    Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
    J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Link between
    Pileckaite E; Vilkeviciute A; Kriauciuniene L; Liutkevicius V; Liutkeviciene R
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases.
    Weiss BG; Bertlich M; Canis M; Ihler F
    Head Neck; 2017 Jun; 39(6):1166-1176. PubMed ID: 28252821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma.
    Li D; Dong P; Wu C; Cao P; Zhou L
    Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):705-10. PubMed ID: 24789803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase β and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
    Ramakodi MP; Devarajan K; Blackman E; Gibbs D; Luce D; Deloumeaux J; Duflo S; Liu JC; Mehra R; Kulathinal RJ; Ragin CC
    Cancer; 2017 Mar; 123(5):849-860. PubMed ID: 27906459
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
    Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.